首页 > 最新文献

Proteoglycan research最新文献

英文 中文
Proteoglycans in Mechanobiology of Tissues and Organs: Normal Functions and Mechanopathology. 组织和器官机械生物学中的蛋白聚糖:正常功能和机械病理学。
Pub Date : 2024-04-01 Epub Date: 2024-05-20 DOI: 10.1002/pgr2.21
Mary C Farach-Carson, Danielle Wu, Cristiane Miranda França

Proteoglycans (PGs) are a diverse class of glycoconjugates that serve critical functions in normal mechanobiology and mechanopathology. Both the protein cores and attached glycosaminoglycan (GAG) chains function in mechanically-sensitive processes, and loss of either can contribute to development of pathological conditions. PGs function as key components of the extracellular matrix (ECM) where they can serve as mechanosensors in mechanosensitive tissues including bone, cartilage, tendon, blood vessels and soft organs. The mechanical properties of these tissues depend on the presence and function of PGs, which play important roles in tissue elasticity, osmolarity and pressure sensing, and response to physical activity. Tissue responses depend on cell surface mechanoreceptors that include integrins, CD44, voltage sensitive ion channels, transient receptor potential (TRP) and piezo channels. PGs contribute to cell and molecular interplay in wound healing, fibrosis, and cancer, where they transduce the mechanical properties of the ECM and influence the progression of various context-specific conditions and diseases. The PGs that are most important in mechanobiology vary depending on the tissue and its functions and functional needs. Perlecan, for example, is important in the mechanobiology of basement membranes, cardiac and skeletal muscle, while aggrecan plays a primary role in the mechanical properties of cartilage and joints. A variety of techniques have been used to study the mechanobiology of PGs, including atomic force microscopy, mouse knockout models, and in vitro cell culture experiments with 3D organoid models. These studies have helped to elucidate the tissue-specific roles that PGs play in cell-level mechanosensing and tissue mechanics. Overall, the study of PGs in mechanobiology is yielding fundamental new concepts in the molecular basis of mechanosensing that can open the door to the development of new treatments for a host of conditions related to mechanopathology.

蛋白多糖(PGs)是一类种类繁多的糖类共轭物,在正常机械生物学和机械病理学中发挥着关键作用。蛋白质核心和附着的糖胺聚糖(GAG)链都在机械敏感过程中发挥作用,其中任何一种功能的缺失都会导致病理状况的发生。PGs 是细胞外基质 (ECM) 的关键成分,可作为骨、软骨、肌腱、血管和软器官等机械敏感组织的机械传感器。这些组织的机械特性取决于 PGs 的存在和功能,PGs 在组织弹性、渗透压和压力感应以及对体力活动的反应方面发挥着重要作用。组织反应取决于细胞表面的机械感受器,其中包括整合素、CD44、电压敏感离子通道、瞬态受体电位(TRP)和压电通道。PGs有助于伤口愈合、纤维化和癌症中的细胞和分子相互作用,它们传递 ECM 的机械特性,并影响各种特定情况和疾病的发展。机械生物学中最重要的 PG 因组织及其功能和功能需求的不同而各异。例如,Perlecan 在基底膜、心肌和骨骼肌的机械生物学中非常重要,而 aggrecan 则在软骨和关节的机械特性中发挥主要作用。研究 PGs 机械生物学的技术多种多样,包括原子力显微镜、小鼠基因敲除模型以及三维类器官模型的体外细胞培养实验。这些研究有助于阐明 PGs 在细胞级机械传感和组织力学中发挥的组织特异性作用。总之,在机械生物学中对 PGs 的研究正在产生机械传感分子基础的基本新概念,这将为开发与机械病理学相关的一系列病症的新疗法打开大门。
{"title":"Proteoglycans in Mechanobiology of Tissues and Organs: Normal Functions and Mechanopathology.","authors":"Mary C Farach-Carson, Danielle Wu, Cristiane Miranda França","doi":"10.1002/pgr2.21","DOIUrl":"10.1002/pgr2.21","url":null,"abstract":"<p><p>Proteoglycans (PGs) are a diverse class of glycoconjugates that serve critical functions in normal mechanobiology and mechanopathology. Both the protein cores and attached glycosaminoglycan (GAG) chains function in mechanically-sensitive processes, and loss of either can contribute to development of pathological conditions. PGs function as key components of the extracellular matrix (ECM) where they can serve as mechanosensors in mechanosensitive tissues including bone, cartilage, tendon, blood vessels and soft organs. The mechanical properties of these tissues depend on the presence and function of PGs, which play important roles in tissue elasticity, osmolarity and pressure sensing, and response to physical activity. Tissue responses depend on cell surface mechanoreceptors that include integrins, CD44, voltage sensitive ion channels, transient receptor potential (TRP) and piezo channels. PGs contribute to cell and molecular interplay in wound healing, fibrosis, and cancer, where they transduce the mechanical properties of the ECM and influence the progression of various context-specific conditions and diseases. The PGs that are most important in mechanobiology vary depending on the tissue and its functions and functional needs. Perlecan, for example, is important in the mechanobiology of basement membranes, cardiac and skeletal muscle, while aggrecan plays a primary role in the mechanical properties of cartilage and joints. A variety of techniques have been used to study the mechanobiology of PGs, including atomic force microscopy, mouse knockout models, and <i>in vitro</i> cell culture experiments with 3D organoid models. These studies have helped to elucidate the tissue-specific roles that PGs play in cell-level mechanosensing and tissue mechanics. Overall, the study of PGs in mechanobiology is yielding fundamental new concepts in the molecular basis of mechanosensing that can open the door to the development of new treatments for a host of conditions related to mechanopathology.</p>","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11584024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142712112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VAR2HP recognizing heparin‐like epitopes in targeted therapy and diagnosis of tumors 在肿瘤靶向治疗和诊断中识别肝素样表位的 VAR2HP
Pub Date : 2024-01-01 DOI: 10.1002/pgr2.16
Yingying Xu, Yi Liu, Ruyi Zou, Xunyi Yuan, Lin Wei, Yong Qin, Xu Wang, Yunxue Zhao, Zhenqiu Yang, Wenshuang Wang, Fuchuan Li
The synthesis of glycosaminoglycans (GAGs) in vivo occurs with high spatiotemporal specificity, and any aberrant expression of GAGs is closely related to the occurrence of diseases. In terms of tumorigenesis, the abnormally expressed GAGs have become a potential target for the diagnosis and therapy of tumors. As previously reported, VAR2HP, a protein probe that recognizes the unique heparin (Hep)‐like epitopes, interacts with a decasaccharide structure containing at least three HexA2S(1‐4)GlcNS6S disaccharides. Its recognition epitopes are overexpressed in various tumor cells and appear promising as target molecules of multiple tumors. Herein, we found that VAR2HP used as an antineoplastic carrier could promote drug enrichment in tumor sites by targeting the specific Hep‐like epitopes on tumor cells, thereby reducing the damage to normal cells in vitro and in vivo. Moreover, VAR2HP acting on cells alone could inhibit cell proliferation, indicating that VAR2HP as a drug carrier has a dual effect of antitumor activity. Additionally, we observed that VAR2HP significantly stained cancer tissues more strongly than neighboring nonmalignant tissues. The staining was competitively inhibited by added exogenous Hep, indicating that the Hep‐like epitopes recognized by VAR2HP were a potential target molecule in tumor diagnosis. Moreover, the VAR2HP‐bound Hep‐like epitopes were found to be overexpressed in the sera of patients with hepatocellular carcinoma (HCC) but not in normal persons and patients with cirrhosis. Taken together, this study shows that VAR2HP and its heparin‐like epitopes have great potential in targeted therapy of tumors and HCC diagnosis.
体内糖胺聚糖(GAGs)的合成具有高度的时空特异性,GAGs的异常表达与疾病的发生密切相关。在肿瘤发生方面,异常表达的 GAGs 已成为肿瘤诊断和治疗的潜在靶点。正如之前所报道的,VAR2HP 是一种能识别独特肝素(Hep)样表位的蛋白探针,它与至少含有三个 HexA2S(1-4)GlcNS6S 二糖的十糖结构相互作用。其识别表位在多种肿瘤细胞中过度表达,有望成为多种肿瘤的靶分子。在此,我们发现,VAR2HP 作为抗肿瘤载体,可通过靶向肿瘤细胞上的特异性 Hep 类表位,促进药物在肿瘤部位的富集,从而减少体外和体内对正常细胞的损伤。此外,VAR2HP 单独作用于细胞可抑制细胞增殖,表明 VAR2HP 作为药物载体具有抗肿瘤活性的双重作用。此外,我们还观察到 VAR2HP 对癌症组织的染色明显强于邻近的非恶性组织。添加外源 Hep 可竞争性抑制该染色,这表明 VAR2HP 识别的 Hep 类表位是肿瘤诊断的潜在靶分子。此外,还发现 VAR2HP 结合的 Hep 类表位在肝细胞癌(HCC)患者血清中过度表达,而在正常人和肝硬化患者血清中则没有。综上所述,本研究表明 VAR2HP 及其肝素样表位在肿瘤靶向治疗和 HCC 诊断方面具有巨大潜力。
{"title":"VAR2HP recognizing heparin‐like epitopes in targeted therapy and diagnosis of tumors","authors":"Yingying Xu, Yi Liu, Ruyi Zou, Xunyi Yuan, Lin Wei, Yong Qin, Xu Wang, Yunxue Zhao, Zhenqiu Yang, Wenshuang Wang, Fuchuan Li","doi":"10.1002/pgr2.16","DOIUrl":"https://doi.org/10.1002/pgr2.16","url":null,"abstract":"The synthesis of glycosaminoglycans (GAGs) in vivo occurs with high spatiotemporal specificity, and any aberrant expression of GAGs is closely related to the occurrence of diseases. In terms of tumorigenesis, the abnormally expressed GAGs have become a potential target for the diagnosis and therapy of tumors. As previously reported, VAR2HP, a protein probe that recognizes the unique heparin (Hep)‐like epitopes, interacts with a decasaccharide structure containing at least three HexA2S(1‐4)GlcNS6S disaccharides. Its recognition epitopes are overexpressed in various tumor cells and appear promising as target molecules of multiple tumors. Herein, we found that VAR2HP used as an antineoplastic carrier could promote drug enrichment in tumor sites by targeting the specific Hep‐like epitopes on tumor cells, thereby reducing the damage to normal cells in vitro and in vivo. Moreover, VAR2HP acting on cells alone could inhibit cell proliferation, indicating that VAR2HP as a drug carrier has a dual effect of antitumor activity. Additionally, we observed that VAR2HP significantly stained cancer tissues more strongly than neighboring nonmalignant tissues. The staining was competitively inhibited by added exogenous Hep, indicating that the Hep‐like epitopes recognized by VAR2HP were a potential target molecule in tumor diagnosis. Moreover, the VAR2HP‐bound Hep‐like epitopes were found to be overexpressed in the sera of patients with hepatocellular carcinoma (HCC) but not in normal persons and patients with cirrhosis. Taken together, this study shows that VAR2HP and its heparin‐like epitopes have great potential in targeted therapy of tumors and HCC diagnosis.","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"16 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140520843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting glypicans through EGFR and JAK/STAT signaling axes drives breast cancer progression 通过表皮生长因子受体和 JAK/STAT 信号轴靶向糖蛋白,推动乳腺癌进展
Pub Date : 2024-01-01 DOI: 10.1002/pgr2.18
Paraskevi Ioannou, Kyriaki Tzaferi, Christos Koutsakis, Z. Piperigkou, Nikos K. Karamanos
Extracellular matrix (ECM) and its dynamic remodeling contribute to the progression of breast cancer, the most prevailing cancer type in women. Glypicans (GPCs) function as cell co‐receptors by facilitating the formation of ligand–receptor complexes. An important regulator in the context of breast cancer progression is the JAK/STAT signaling pathway that oversees the expression of genes associated with cancer cell characteristics. Epidermal growth factor receptor (EGFR) is a pivotal player in this process. The aim of this study is to examine the effect of the EGFR and JAK/STAT signaling pathways on GPCs expression in breast cancer cells with different estrogen receptor (ER) status, depicting different breast cancer subtypes. To this end, the ERα‐positive MCF‐7, and the ERβ‐positive MDA‐MB‐231 breast cancer cell lines were evaluated in terms of the impact of downstream inhibition of both pathways on the functional properties as well as the expression of GPCs 1‐6 genes. Notably, the downstream inhibition of both EGFR and JAK/STAT cascades mitigate cell proliferation and migration, while increasing cell adhesion on collagen type I in an ER‐independent manner. However, the inhibition exhibited a cell‐line‐dependent effect on GPC expression, as in MCF‐7 cells GPCs expression is mostly downregulated excepting GPC‐4 and GPC‐5. Conversely, in MDA‐MB‐231 cells, EGFR and JAK/STAT activation is essential for maintaining GPCs at low levels. Additionally, STRING analysis identified the small leucine‐rich PG decorin as a putative link between all GPCs and EGFR. Subsequently, a deeper understanding on the effect of EGFR and JAK/STAT signaling may shed light into the role and interplay between GPCs and decorin in breast cancer progression, thus contributing to novel therapeutic solutions.
细胞外基质(ECM)及其动态重塑是乳腺癌(女性最常见的癌症类型)恶化的原因之一。糖蛋白(GPCs)通过促进配体-受体复合物的形成,起到细胞共受体的作用。JAK/STAT 信号通路是乳腺癌进展过程中的一个重要调节因子,它负责监督与癌细胞特征相关的基因的表达。表皮生长因子受体(EGFR)在这一过程中起着关键作用。本研究的目的是研究表皮生长因子受体和 JAK/STAT 信号通路对不同雌激素受体(ER)状态的乳腺癌细胞中 GPCs 表达的影响,从而描述不同的乳腺癌亚型。为此,研究人员对ERα阳性的MCF-7和ERβ阳性的MDA-MB-231乳腺癌细胞系进行了评估,研究这两种途径的下游抑制对GPCs 1-6基因的功能特性和表达的影响。值得注意的是,对表皮生长因子受体和 JAK/STAT 级联的下游抑制可减轻细胞的增殖和迁移,同时以一种与 ER 无关的方式增加细胞对 I 型胶原的粘附力。然而,这种抑制作用对 GPC 的表达具有细胞系依赖性,因为在 MCF-7 细胞中,除 GPC-4 和 GPC-5 外,GPCs 的表达大多下调。相反,在 MDA-MB-231 细胞中,表皮生长因子受体(EGFR)和 JAK/STAT 的激活对维持低水平的 GPCs 至关重要。此外,通过 STRING 分析发现,富含亮氨酸的小 PG 装饰素可能是所有 GPC 与表皮生长因子受体之间的联系。因此,更深入地了解表皮生长因子受体和 JAK/STAT 信号转导的影响可能会揭示 GPCs 和装饰素在乳腺癌进展中的作用和相互作用,从而有助于找到新的治疗方案。
{"title":"Targeting glypicans through EGFR and JAK/STAT signaling axes drives breast cancer progression","authors":"Paraskevi Ioannou, Kyriaki Tzaferi, Christos Koutsakis, Z. Piperigkou, Nikos K. Karamanos","doi":"10.1002/pgr2.18","DOIUrl":"https://doi.org/10.1002/pgr2.18","url":null,"abstract":"Extracellular matrix (ECM) and its dynamic remodeling contribute to the progression of breast cancer, the most prevailing cancer type in women. Glypicans (GPCs) function as cell co‐receptors by facilitating the formation of ligand–receptor complexes. An important regulator in the context of breast cancer progression is the JAK/STAT signaling pathway that oversees the expression of genes associated with cancer cell characteristics. Epidermal growth factor receptor (EGFR) is a pivotal player in this process. The aim of this study is to examine the effect of the EGFR and JAK/STAT signaling pathways on GPCs expression in breast cancer cells with different estrogen receptor (ER) status, depicting different breast cancer subtypes. To this end, the ERα‐positive MCF‐7, and the ERβ‐positive MDA‐MB‐231 breast cancer cell lines were evaluated in terms of the impact of downstream inhibition of both pathways on the functional properties as well as the expression of GPCs 1‐6 genes. Notably, the downstream inhibition of both EGFR and JAK/STAT cascades mitigate cell proliferation and migration, while increasing cell adhesion on collagen type I in an ER‐independent manner. However, the inhibition exhibited a cell‐line‐dependent effect on GPC expression, as in MCF‐7 cells GPCs expression is mostly downregulated excepting GPC‐4 and GPC‐5. Conversely, in MDA‐MB‐231 cells, EGFR and JAK/STAT activation is essential for maintaining GPCs at low levels. Additionally, STRING analysis identified the small leucine‐rich PG decorin as a putative link between all GPCs and EGFR. Subsequently, a deeper understanding on the effect of EGFR and JAK/STAT signaling may shed light into the role and interplay between GPCs and decorin in breast cancer progression, thus contributing to novel therapeutic solutions.","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140524082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heparanase‐1 and MMPs in Covid‐19 and non‐Covid‐19 pneumonia Covid-19和非Covid-19肺炎中的肝素酶-1和MMPs
Pub Date : 2024-01-01 DOI: 10.1002/pgr2.14
V. Masola, G. Marrone, Carola Condoluci, Marco Franchi, Leonardo Stella, M. Biolato, Luca Miele, Giovanni Gambaro, Claudia Dal Vecchio, M. Onisto
Together with the ACE2 protein, heparan sulfate present at the level of the glycocalyx in the lung epithelia is considered a cellular “co‐receptor” for the viral spike protein that allows severe acute respiratory syndrome coronavirus 2 (SARS‐CoV) to infect cells. An increase in the amount and activity of heparanase‐1 (HPSE), the only enzyme capable of degrading the heparan sulfate (HS) chains of the glycocalyx and of the extracellular matrix, has been described in the plasma of patients affected by coronavirus disease 2019 (Covid‐19). Furthermore, the activity of matrix metalloproteases, or MMPs, has been related to matrix degradation, oxidative stress, and inflammation in Covid‐19 patients. In this study, we enrolled 26 Covid‐19 patients and 15 controls with diagnosis of non‐SARS‐CoV‐2‐related pneumonia. We evaluated the expression and activity of HPSE and the expression of MMPs in their serum together with other clinical markers of disease and inflammation. Results proved that HPSE expression and activity serum levels were significantly increased, whereas MMP2 and 9 were decreased in Covid‐19 versus non‐Covid‐19 pneumonia patients. In addition, IL‐6 levels were higher, whereas platelet and white blood cells were lower in Covid‐19 with respect to non‐Covid‐19 pneumonia. Moreover, MMP9 but not HPSE (expression and activity) levels were increased in Covid‐19 pneumonia patients with ongoing lung alteration over time. In summary, the present findings indicate that HPSE and MMPs are differentially regulated in Covid‐19 and non‐Covid‐19 pneumonia.
与 ACE2 蛋白一起,存在于肺上皮细胞糖萼水平的硫酸肝素被认为是病毒尖峰蛋白的细胞 "共受体",它使严重急性呼吸系统综合征冠状病毒 2(SARS-CoV)能够感染细胞。据描述,2019 年冠状病毒病(Covid-19)患者血浆中肝素酶-1(HPSE)的数量和活性增加,而肝素酶-1 是唯一能够降解糖萼和细胞外基质中硫酸肝素(HS)链的酶。此外,基质金属蛋白酶(MMPs)的活性与 Covid-19 患者的基质降解、氧化应激和炎症有关。在这项研究中,我们招募了 26 名 Covid-19 患者和 15 名对照组患者,他们都被诊断为非 SARS-CoV-2 相关肺炎。我们评估了他们血清中 HPSE 的表达和活性以及 MMPs 的表达,同时还评估了其他疾病和炎症的临床指标。结果证明,与非 Covid-19 肺炎患者相比,Covid-19 肺炎患者血清中 HPSE 的表达和活性水平明显升高,而 MMP2 和 9 则有所降低。此外,Covid-19 与非 Covid-19 肺炎患者相比,IL-6 水平更高,而血小板和白细胞水平更低。此外,Covid-19 肺炎患者的 MMP9(表达和活性)水平升高,而 HPSE(表达和活性)水平未升高,且随着时间的推移,肺部改变仍在持续。总之,本研究结果表明,在 Covid-19 肺炎和非 Covid-19 肺炎中,HPSE 和 MMPs 受到不同程度的调控。
{"title":"Heparanase‐1 and MMPs in Covid‐19 and non‐Covid‐19 pneumonia","authors":"V. Masola, G. Marrone, Carola Condoluci, Marco Franchi, Leonardo Stella, M. Biolato, Luca Miele, Giovanni Gambaro, Claudia Dal Vecchio, M. Onisto","doi":"10.1002/pgr2.14","DOIUrl":"https://doi.org/10.1002/pgr2.14","url":null,"abstract":"Together with the ACE2 protein, heparan sulfate present at the level of the glycocalyx in the lung epithelia is considered a cellular “co‐receptor” for the viral spike protein that allows severe acute respiratory syndrome coronavirus 2 (SARS‐CoV) to infect cells. An increase in the amount and activity of heparanase‐1 (HPSE), the only enzyme capable of degrading the heparan sulfate (HS) chains of the glycocalyx and of the extracellular matrix, has been described in the plasma of patients affected by coronavirus disease 2019 (Covid‐19). Furthermore, the activity of matrix metalloproteases, or MMPs, has been related to matrix degradation, oxidative stress, and inflammation in Covid‐19 patients. In this study, we enrolled 26 Covid‐19 patients and 15 controls with diagnosis of non‐SARS‐CoV‐2‐related pneumonia. We evaluated the expression and activity of HPSE and the expression of MMPs in their serum together with other clinical markers of disease and inflammation. Results proved that HPSE expression and activity serum levels were significantly increased, whereas MMP2 and 9 were decreased in Covid‐19 versus non‐Covid‐19 pneumonia patients. In addition, IL‐6 levels were higher, whereas platelet and white blood cells were lower in Covid‐19 with respect to non‐Covid‐19 pneumonia. Moreover, MMP9 but not HPSE (expression and activity) levels were increased in Covid‐19 pneumonia patients with ongoing lung alteration over time. In summary, the present findings indicate that HPSE and MMPs are differentially regulated in Covid‐19 and non‐Covid‐19 pneumonia.","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"78 1-2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140523712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vivo activities of heparan sulfate differentially modified by NDSTs during development 发育过程中被 NDSTs 不同修饰的硫酸肝素的体内活性
Pub Date : 2024-01-01 DOI: 10.1002/pgr2.17
E. Nakato, Sarah Baker, A. Kinoshita-Toyoda, Collin Knudsen, Yi‐Si Lu, Masahiko Takemura, Hidenao Toyoda, H. Nakato
Heparan sulfate proteoglycans (HSPGs) serve as co‐receptors for growth factor signaling during development. It is well known that the level and patterns of sulfate groups of heparan sulfate (HS) chains, or HS fine structures, have a major impact on HSPG function. On the other hand, the physiological significance of other structural features of HS, including NS/NA domain organization, remains to be elucidated. A blueprint of the HS domain structures is mainly controlled by HS N‐deacetylase/N‐sulfotransferases (NDSTs). To analyze in vivo activities of differentially modified HS, we established two knock‐in (KI) Drosophila strains with the insertion of mouse Ndst1 (mNdst1) or Ndst2 (mNdst2) in the locus of sulfateless (sfl), the only Drosophila NDST. In these KI lines, mNDSTs are expressed from the sfl locus, in the level and patterns identical to the endogenous sfl gene. Thus, phenotypes of Ndst1 KI and Ndst2KI animals reflect the ability of HS structures made by these enzymes to rescue sfl mutation. Remarkably, we found that mNdst1 completely rescued the loss of sfl. mNdst2 showed a limited rescue ability, despite a higher level of HS sulfation compared to HS in mNdst1 KI. Our study suggests that independent of sulfation levels, additional HS structural features controlled by NDSTs play key roles during tissue patterning.
硫酸肝素蛋白聚糖(HSPGs)在发育过程中是生长因子信号的共受体。众所周知,硫酸肝素(HS)链上硫酸基团的水平和模式或 HS 的精细结构对 HSPG 的功能有重大影响。另一方面,HS 的其他结构特征(包括 NS/NA 结构域组织)的生理意义仍有待阐明。HS结构域的蓝图主要由HS N-脱乙酰酶/N-硫转移酶(NDSTs)控制。为了分析不同修饰的HS在体内的活性,我们在果蝇唯一的NDST--无硫(ssl)基因座上插入了小鼠Ndst1(mNdst1)或Ndst2(mNdst2),建立了两个基因敲入(KI)果蝇品系。在这些 KI 株系中,mNDSTs 从 sfl 基因座表达,表达水平和模式与内源 sfl 基因相同。因此,Ndst1 KI 和 Ndst2KI 动物的表型反映了这些酶产生的 HS 结构挽救 sfl 突变的能力。值得注意的是,我们发现 mNdst1 能完全拯救 sfl 基因的缺失,而 mNdst2 的拯救能力有限,尽管与 mNdst1 KI 中的 HS 相比,mNdst2 的 HS 硫酸化水平更高。我们的研究表明,与硫酸化水平无关,由 NDSTs 控制的其他 HS 结构特征在组织形态形成过程中发挥着关键作用。
{"title":"In vivo activities of heparan sulfate differentially modified by NDSTs during development","authors":"E. Nakato, Sarah Baker, A. Kinoshita-Toyoda, Collin Knudsen, Yi‐Si Lu, Masahiko Takemura, Hidenao Toyoda, H. Nakato","doi":"10.1002/pgr2.17","DOIUrl":"https://doi.org/10.1002/pgr2.17","url":null,"abstract":"Heparan sulfate proteoglycans (HSPGs) serve as co‐receptors for growth factor signaling during development. It is well known that the level and patterns of sulfate groups of heparan sulfate (HS) chains, or HS fine structures, have a major impact on HSPG function. On the other hand, the physiological significance of other structural features of HS, including NS/NA domain organization, remains to be elucidated. A blueprint of the HS domain structures is mainly controlled by HS N‐deacetylase/N‐sulfotransferases (NDSTs). To analyze in vivo activities of differentially modified HS, we established two knock‐in (KI) Drosophila strains with the insertion of mouse Ndst1 (mNdst1) or Ndst2 (mNdst2) in the locus of sulfateless (sfl), the only Drosophila NDST. In these KI lines, mNDSTs are expressed from the sfl locus, in the level and patterns identical to the endogenous sfl gene. Thus, phenotypes of Ndst1 KI and Ndst2KI animals reflect the ability of HS structures made by these enzymes to rescue sfl mutation. Remarkably, we found that mNdst1 completely rescued the loss of sfl. mNdst2 showed a limited rescue ability, despite a higher level of HS sulfation compared to HS in mNdst1 KI. Our study suggests that independent of sulfation levels, additional HS structural features controlled by NDSTs play key roles during tissue patterning.","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"76 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140524922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel biomimetic probe for galectin‐3 recognition: Chemical synthesis and structural characterization of a β‐galactose branched sodium hyaluronate 识别 galectin-3 的新型仿生物探针:β-半乳糖支链透明质酸钠的化学合成与结构表征
Pub Date : 2024-01-01 DOI: 10.1002/pgr2.19
Sofia Nizzolo, Emiliano Esposito, Ming‐Hong Ni, Laura Bertocchi, Giulio Bianchini, Nadia Freato, Serena Zanzoni, Marco Guerrini, Sabrina Bertini
Sodium hyaluronate (HA), a derivative of hyaluronan, is a natural and biocompatible polysaccharide that interacts with cluster of differentiation‐44 receptor to promote fine‐tuning of inflammation, fibrosis, and tissue remodeling. HA has a smaller molecular weight than hyaluronan and is overall more stable being less prone to oxidation. In this study, we report a novel lactose‐functionalized sodium hyaluronate, named HYLACH®. Functionalization with multiple β‐galactose residues facilitates its interaction with galectin‐3, a β‐galactose binding lectin implicated in various pathological processes including inflammation, host defense, and fibrosis, especially critical in idiopathic pulmonary fibrosis (IPF). Our strategy was to modify HA, to varying extents, at carboxyl sites with 1‐amino‐1‐deoxy‐lactitol, in the presence of 4‐(4,6‐dimethoxy‐1,3,5‐triazin‐2‐yl)‐4‐methyl morpholinium chloride in aqueous media. We characterized the chemical structure, molecular weight, and degree of substitution of HYLACH® using NMR spectroscopy and size exclusion chromatography. We further determined several key parameters including its stability toward enzymatic degradation and the binding affinity and conformational changes of galectin‐3 interaction with HYLACH®. Collectively, the generation of a novel functionalized HA with an ability to bind and suppress galectin‐3 function, in combination with safety and biocompatibility, offers the opportunity to test this compound in therapeutic trials of devastating fibrotic diseases such as IPF.
透明质酸钠(HA)是透明质酸的衍生物,是一种天然的生物相容性多糖,可与分化-44 受体群相互作用,促进炎症、纤维化和组织重塑的微调。与透明质酸相比,HA 的分子量更小,而且总体上更稳定,不易氧化。在这项研究中,我们报告了一种新型乳糖功能化透明质酸钠,名为 HYLACH®。多个β-半乳糖残基的功能化促进了透明质酸钠与半乳糖凝集素-3的相互作用,半乳糖凝集素-3是一种与炎症、宿主防御和纤维化等各种病理过程有关的β-半乳糖结合凝集素,在特发性肺纤维化(IPF)中尤为关键。我们的策略是在水介质中,在 4-(4,6-二甲氧基-1,3,5-三嗪-2-基)-4-甲基吗啉氯化物的存在下,用 1-氨基-1-脱氧-乳糖醇对 HA 的羧基位点进行不同程度的修饰。我们利用核磁共振光谱和尺寸排阻色谱法确定了 HYLACH® 的化学结构、分子量和取代度。我们还进一步确定了几个关键参数,包括其酶降解稳定性、结合亲和力以及 galectin-3 与 HYLACH® 相互作用的构象变化。总之,新型功能化 HA 的产生具有结合和抑制 galectin-3 功能的能力,同时兼具安全性和生物相容性,这为在 IPF 等破坏性纤维化疾病的治疗试验中测试这种化合物提供了机会。
{"title":"A novel biomimetic probe for galectin‐3 recognition: Chemical synthesis and structural characterization of a β‐galactose branched sodium hyaluronate","authors":"Sofia Nizzolo, Emiliano Esposito, Ming‐Hong Ni, Laura Bertocchi, Giulio Bianchini, Nadia Freato, Serena Zanzoni, Marco Guerrini, Sabrina Bertini","doi":"10.1002/pgr2.19","DOIUrl":"https://doi.org/10.1002/pgr2.19","url":null,"abstract":"Sodium hyaluronate (HA), a derivative of hyaluronan, is a natural and biocompatible polysaccharide that interacts with cluster of differentiation‐44 receptor to promote fine‐tuning of inflammation, fibrosis, and tissue remodeling. HA has a smaller molecular weight than hyaluronan and is overall more stable being less prone to oxidation. In this study, we report a novel lactose‐functionalized sodium hyaluronate, named HYLACH®. Functionalization with multiple β‐galactose residues facilitates its interaction with galectin‐3, a β‐galactose binding lectin implicated in various pathological processes including inflammation, host defense, and fibrosis, especially critical in idiopathic pulmonary fibrosis (IPF). Our strategy was to modify HA, to varying extents, at carboxyl sites with 1‐amino‐1‐deoxy‐lactitol, in the presence of 4‐(4,6‐dimethoxy‐1,3,5‐triazin‐2‐yl)‐4‐methyl morpholinium chloride in aqueous media. We characterized the chemical structure, molecular weight, and degree of substitution of HYLACH® using NMR spectroscopy and size exclusion chromatography. We further determined several key parameters including its stability toward enzymatic degradation and the binding affinity and conformational changes of galectin‐3 interaction with HYLACH®. Collectively, the generation of a novel functionalized HA with an ability to bind and suppress galectin‐3 function, in combination with safety and biocompatibility, offers the opportunity to test this compound in therapeutic trials of devastating fibrotic diseases such as IPF.","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"105 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140515769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chondroitin sulfate proteoglycan promotes APRIL‐induced tumor cell proliferation 硫酸软骨素蛋白多糖促进 APRIL 诱导的肿瘤细胞增殖
Pub Date : 2024-01-01 DOI: 10.1002/pgr2.15
S. Nadanaka, Toshiyasu Koike, Hiroshi Kitagawa
A proliferation‐inducing ligand (APRIL), a member of the tumor necrosis factor superfamily, affects the survival and proliferation of tumor cells. Understanding the mechanism of action of APRIL in tumor cells, including intracellular signaling, is important for its potential use in diagnostics and prognosis. It has been shown that APRIL‐induced tumor proliferation requires heparan sulfate (HS) proteoglycans to mediate the binding of APRIL to tumor cells. Here, we show that chondroitin sulfate (CS) proteoglycan mainly contributes to the APRIL‐stimulated proliferation of triple‐negative breast cancer BT‐549 cells. Knockout of chondroitin 4‐O‐sulfotransferase‐1 (C4ST‐1), a key CS biosynthetic enzyme, suppressed APRIL‐induced tumor proliferation, whereas deficiency of exostosin 1 (EXT1), a key HS biosynthetic enzyme, had only weak effects. Molecular interaction analyses using Biacore revealed that although CS did not directly bind to tumor growth through Ca2+ modulator interactor (TACI), it enhanced the binding of APRIL to the APRIL receptor, TACI. The small leucine‐rich proteoglycan, biglycan, plays a pivotal role in tumor growth and progression. Biglycan knockdown inhibited BT‐549 cell proliferation. These results suggest that CS synthesized by C4ST‐1 participates in APRIL signaling and modulates pathological events in tumors.
增殖诱导配体(APRIL)是肿瘤坏死因子超家族的成员之一,会影响肿瘤细胞的存活和增殖。了解 APRIL 在肿瘤细胞中的作用机制(包括细胞内信号传导)对其在诊断和预后中的潜在应用非常重要。研究表明,APRIL 诱导的肿瘤增殖需要硫酸肝素(HS)蛋白多糖介导 APRIL 与肿瘤细胞的结合。在这里,我们发现硫酸软骨素(CS)蛋白多糖主要促进了三阴性乳腺癌BT-549细胞在APRIL刺激下的增殖。敲除软骨素 4-O-磺基转移酶-1(C4ST-1)--一种关键的 CS 生物合成酶--抑制了 APRIL 诱导的肿瘤增殖,而缺乏外ostosin 1(EXT1)--一种关键的 HS 生物合成酶--只有微弱的影响。利用 Biacore 进行的分子相互作用分析表明,尽管 CS 没有通过 Ca2+ 调制剂相互作用因子(TACI)直接与肿瘤生长结合,但它增强了 APRIL 与 APRIL 受体 TACI 的结合。富含亮氨酸的小蛋白多糖(biglycan)在肿瘤生长和进展中起着关键作用。敲除 Biglycan 可抑制 BT-549 细胞的增殖。这些结果表明,C4ST-1合成的CS参与了APRIL信号转导,并调节肿瘤的病理事件。
{"title":"Chondroitin sulfate proteoglycan promotes APRIL‐induced tumor cell proliferation","authors":"S. Nadanaka, Toshiyasu Koike, Hiroshi Kitagawa","doi":"10.1002/pgr2.15","DOIUrl":"https://doi.org/10.1002/pgr2.15","url":null,"abstract":"A proliferation‐inducing ligand (APRIL), a member of the tumor necrosis factor superfamily, affects the survival and proliferation of tumor cells. Understanding the mechanism of action of APRIL in tumor cells, including intracellular signaling, is important for its potential use in diagnostics and prognosis. It has been shown that APRIL‐induced tumor proliferation requires heparan sulfate (HS) proteoglycans to mediate the binding of APRIL to tumor cells. Here, we show that chondroitin sulfate (CS) proteoglycan mainly contributes to the APRIL‐stimulated proliferation of triple‐negative breast cancer BT‐549 cells. Knockout of chondroitin 4‐O‐sulfotransferase‐1 (C4ST‐1), a key CS biosynthetic enzyme, suppressed APRIL‐induced tumor proliferation, whereas deficiency of exostosin 1 (EXT1), a key HS biosynthetic enzyme, had only weak effects. Molecular interaction analyses using Biacore revealed that although CS did not directly bind to tumor growth through Ca2+ modulator interactor (TACI), it enhanced the binding of APRIL to the APRIL receptor, TACI. The small leucine‐rich proteoglycan, biglycan, plays a pivotal role in tumor growth and progression. Biglycan knockdown inhibited BT‐549 cell proliferation. These results suggest that CS synthesized by C4ST‐1 participates in APRIL signaling and modulates pathological events in tumors.","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"9 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139633520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Versican and versikine: The dynamism of the extracellular matrix Versican和versikine:细胞外基质的活力
Pub Date : 2023-10-01 DOI: 10.1002/pgr2.13
Hideto Watanabe
Versican is a large chondroitin sulfate/dermatan sulfate proteoglycan in the extracellular matrix and one of the aggrecan/lectican family. Whereas versican is constitutively expressed and serves as a structural macromolecule in some tissues, it is transiently expressed at high levels when the extracellular matrix dynamically changes. There, versican plays an important role in forming the provisional matrix, which is replaced with the “authentic” extracellular matrix, that is, the matrix as it should be. ADAMTS‐1, 4, 5, 9, 15, and 20 cleave versican core protein and are therefore named versicanases. These proteinases have been believed to play a critical role in versican turnover. A cleaved N‐terminal fragment harbors biological functions, and it is termed “versikine.” This review discusses recent advances in the research on the in vivo function of versican and versikine generated by versicanases.
Versican 是细胞外基质中的一种大型硫酸软骨素/硫酸软骨素蛋白多糖,也是 aggrecan/lectican 家族中的一种。versican 在某些组织中构成性表达,是一种结构性大分子,但当细胞外基质发生动态变化时,它也会瞬时高水平表达。在这种情况下, versican 在形成临时基质(provisional matrix)方面发挥着重要作用,临时基质会被 "真正的 "细胞外基质(即应有的基质)所取代。ADAMTS-1、4、5、9、15 和 20 能裂解 versican 核心蛋白,因此被命名为 versican 酶。这些蛋白酶被认为在 versican 的转换过程中起着关键作用。被裂解的 N 端片段具有生物学功能,被称为 "versikine"。本综述讨论了有关 versican 和 versican 酶产生的 versikine 体内功能研究的最新进展。
{"title":"Versican and versikine: The dynamism of the extracellular matrix","authors":"Hideto Watanabe","doi":"10.1002/pgr2.13","DOIUrl":"https://doi.org/10.1002/pgr2.13","url":null,"abstract":"Versican is a large chondroitin sulfate/dermatan sulfate proteoglycan in the extracellular matrix and one of the aggrecan/lectican family. Whereas versican is constitutively expressed and serves as a structural macromolecule in some tissues, it is transiently expressed at high levels when the extracellular matrix dynamically changes. There, versican plays an important role in forming the provisional matrix, which is replaced with the “authentic” extracellular matrix, that is, the matrix as it should be. ADAMTS‐1, 4, 5, 9, 15, and 20 cleave versican core protein and are therefore named versicanases. These proteinases have been believed to play a critical role in versican turnover. A cleaved N‐terminal fragment harbors biological functions, and it is termed “versikine.” This review discusses recent advances in the research on the in vivo function of versican and versikine generated by versicanases.","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"134 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139330868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heparanase-A single protein with multiple enzymatic and nonenzymatic functions. 庚二酸--具有多种酶和非酶功能的单一蛋白质。
Pub Date : 2023-07-01 Epub Date: 2023-07-09 DOI: 10.1002/pgr2.6
Israel Vlodavsky, Yasmin Kayal, Maram Hilwi, Soaad Soboh, Ralph D Sanderson, Neta Ilan

Heparanase (Hpa1) is expressed by tumor cells and cells of the tumor microenvironment and functions extracellularly to remodel the extracellular matrix (ECM) and regulate the bioavailability of ECM-bound factors, augmenting, among other effects, gene transcription, autophagy, exosome formation, and heparan sulfate (HS) turnover. Much of the impact of heparanase on tumor progression is related to its function in mediating tumor-host crosstalk, priming the tumor microenvironment to better support tumor growth, metastasis, and chemoresistance. The enzyme appears to fulfill some normal functions associated, for example, with vesicular traffic, lysosomal-based secretion, autophagy, HS turnover, and gene transcription. It activates cells of the innate immune system, promotes the formation of exosomes and autophagosomes, and stimulates signal transduction pathways via enzymatic and nonenzymatic activities. These effects dynamically impact multiple regulatory pathways that together drive tumor growth, dissemination, and drug resistance as well as inflammatory responses. The emerging premise is that heparanase expressed by tumor cells, immune cells, endothelial cells, and other cells of the tumor microenvironment is a key regulator of the aggressive phenotype of cancer, an important contributor to the poor outcome of cancer patients and a valid target for therapy. So far, however, antiheparanase-based therapy has not been implemented in the clinic. Unlike heparanase, heparanase-2 (Hpa2), a close homolog of heparanase (Hpa1), does not undergo proteolytic processing and hence lacks intrinsic HS-degrading activity, the hallmark of heparanase. Hpa2 retains the capacity to bind heparin/HS and exhibits an even higher affinity towards HS than heparanase, thus competing for HS binding and inhibiting heparanase enzymatic activity. It appears that Hpa2 functions as a natural inhibitor of Hpa1 regulates the expression of selected genes that maintain tissue hemostasis and normal function, and plays a protective role against cancer and inflammation, together emphasizing the significance of maintaining a proper balance between Hpa1 and Hpa2.

肝素酶(Hpa1)由肿瘤细胞和肿瘤微环境细胞表达,在细胞外发挥重塑细胞外基质(ECM)和调节 ECM 结合因子生物利用度的功能,除其他作用外,还能增强基因转录、自噬、外泌体形成和硫酸肝素(HS)周转。硫酸肝素酶对肿瘤进展的影响主要与其介导肿瘤-宿主串联的功能有关,它可使肿瘤微环境更好地支持肿瘤生长、转移和化疗抗性。这种酶似乎能发挥一些正常功能,例如与囊泡运输、溶酶体分泌、自噬、HS 更替和基因转录有关的功能。它能激活先天性免疫系统细胞,促进外泌体和自噬体的形成,并通过酶和非酶活性刺激信号转导途径。这些作用对多种调节途径产生动态影响,共同推动肿瘤的生长、扩散、耐药性和炎症反应。新的前提是,由肿瘤细胞、免疫细胞、内皮细胞和肿瘤微环境中其他细胞表达的肝素酶是癌症侵袭表型的关键调节因子,是导致癌症患者预后不良的重要因素,也是有效的治疗靶点。然而,迄今为止,基于抗肝素酶的疗法尚未应用于临床。与肝素酶不同,肝素酶-2(Hpa2)是肝素酶(Hpa1)的近缘同源物,不经过蛋白水解加工,因此缺乏肝素酶的标志--内在的HS降解活性。Hpa2 保留了与肝素/HS 结合的能力,对 HS 的亲和力甚至比肝素酶更高,从而竞争性地与 HS 结合并抑制肝素酶的酶活性。由此看来,Hpa2 的功能是作为 Hpa1 的天然抑制剂,调节维持组织止血和正常功能的特定基因的表达,并对癌症和炎症起到保护作用。
{"title":"Heparanase-A single protein with multiple enzymatic and nonenzymatic functions.","authors":"Israel Vlodavsky, Yasmin Kayal, Maram Hilwi, Soaad Soboh, Ralph D Sanderson, Neta Ilan","doi":"10.1002/pgr2.6","DOIUrl":"10.1002/pgr2.6","url":null,"abstract":"<p><p>Heparanase (Hpa1) is expressed by tumor cells and cells of the tumor microenvironment and functions extracellularly to remodel the extracellular matrix (ECM) and regulate the bioavailability of ECM-bound factors, augmenting, among other effects, gene transcription, autophagy, exosome formation, and heparan sulfate (HS) turnover. Much of the impact of heparanase on tumor progression is related to its function in mediating tumor-host crosstalk, priming the tumor microenvironment to better support tumor growth, metastasis, and chemoresistance. The enzyme appears to fulfill some normal functions associated, for example, with vesicular traffic, lysosomal-based secretion, autophagy, HS turnover, and gene transcription. It activates cells of the innate immune system, promotes the formation of exosomes and autophagosomes, and stimulates signal transduction pathways via enzymatic and nonenzymatic activities. These effects dynamically impact multiple regulatory pathways that together drive tumor growth, dissemination, and drug resistance as well as inflammatory responses. The emerging premise is that heparanase expressed by tumor cells, immune cells, endothelial cells, and other cells of the tumor microenvironment is a key regulator of the aggressive phenotype of cancer, an important contributor to the poor outcome of cancer patients and a valid target for therapy. So far, however, antiheparanase-based therapy has not been implemented in the clinic. Unlike heparanase, heparanase-2 (Hpa2), a close homolog of heparanase (Hpa1), does not undergo proteolytic processing and hence lacks intrinsic HS-degrading activity, the hallmark of heparanase. Hpa2 retains the capacity to bind heparin/HS and exhibits an even higher affinity towards HS than heparanase, thus competing for HS binding and inhibiting heparanase enzymatic activity. It appears that Hpa2 functions as a natural inhibitor of Hpa1 regulates the expression of selected genes that maintain tissue hemostasis and normal function, and plays a protective role against cancer and inflammation, together emphasizing the significance of maintaining a proper balance between Hpa1 and Hpa2.</p>","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"1 3","pages":"e6"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10325441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The functional network of biglycan: A new frontier in tumor progression biglycan的功能网络:肿瘤进展的新前沿
Pub Date : 2023-07-01 DOI: 10.1002/pgr2.11
Li Yu, Nako Maishi, Aya Matsuda, Kyoko Hida
Abstract Biglycan is a member of the small leucine‐rich proteoglycan family. Dysregulation of biglycan leads to a broad range of clinical consequences, such as osteoclastogenesis, inflammation, cardiovascular disease, and cancer. Biglycan binding to toll‐like receptor (TLR)−2 or TLR‐4 on immune cells lead to infiltration of immune cells to mediate the inflammatory response. Additionally, the extracellular matrix‐secreted soluble biglycan functions as a danger‐associated molecular pattern molecule involved in the induction of inflammation and cancer. High expression of biglycan is demonstrated in tumor endothelial cells (TECs) of various cancers and correlates with metastatic potential and poor clinical outcomes. This comprehensive review addresses the role of biglycan in both tumor cells and tumor stromal cells, especially TECs, in regulating tumor angiogenesis, tumor growth, metastasis, and chemotherapy resistance.
Biglycan是富含亮氨酸的小蛋白聚糖家族的一员。biglycan的失调会导致广泛的临床后果,如破骨细胞生成、炎症、心血管疾病和癌症。Biglycan与免疫细胞上toll样受体(TLR)−2或TLR‐4结合,导致免疫细胞浸润,介导炎症反应。此外,细胞外基质分泌的可溶性多糖作为一种危险相关的分子模式分子参与炎症和癌症的诱导。biglycan在多种癌症的肿瘤内皮细胞(TECs)中高表达,并与转移潜力和不良临床结果相关。本文综述了巨多糖在肿瘤细胞和肿瘤基质细胞中的作用,特别是在调节肿瘤血管生成、肿瘤生长、转移和化疗耐药方面的作用。
{"title":"The functional network of biglycan: A new frontier in tumor progression","authors":"Li Yu, Nako Maishi, Aya Matsuda, Kyoko Hida","doi":"10.1002/pgr2.11","DOIUrl":"https://doi.org/10.1002/pgr2.11","url":null,"abstract":"Abstract Biglycan is a member of the small leucine‐rich proteoglycan family. Dysregulation of biglycan leads to a broad range of clinical consequences, such as osteoclastogenesis, inflammation, cardiovascular disease, and cancer. Biglycan binding to toll‐like receptor (TLR)−2 or TLR‐4 on immune cells lead to infiltration of immune cells to mediate the inflammatory response. Additionally, the extracellular matrix‐secreted soluble biglycan functions as a danger‐associated molecular pattern molecule involved in the induction of inflammation and cancer. High expression of biglycan is demonstrated in tumor endothelial cells (TECs) of various cancers and correlates with metastatic potential and poor clinical outcomes. This comprehensive review addresses the role of biglycan in both tumor cells and tumor stromal cells, especially TECs, in regulating tumor angiogenesis, tumor growth, metastasis, and chemotherapy resistance.","PeriodicalId":74585,"journal":{"name":"Proteoglycan research","volume":"148 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136260470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Proteoglycan research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1